Diffuse large B-cell lymphoma, multilocalized and extranodal in adult with complete remission: a case report

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphomas. The current classification recognizes an expanding group of distinct entities, with this being the most common. Up to one-third of DLBCL cases may originate in nearly any organ, most commonly in the gastrointestinal tract, skin and soft tissues, bones, or genitourinary tract. A 52-year-old woman with no history of chronic degenerative diseases presented with severe abdominal pain, weight loss, and night sweats. As part of her evaluation, an abdominopelvic CT scan was performed, revealing splenomegaly with internal nodular lesions of undetermined origin, inguinal lymphadenopathy, and cutaneous involvement. A lymphoproliferative process was suggested among the differential diagnoses. Immunohistochemical studies confirmed DLBCL. The patient subsequently received treatment with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), achieving a cure rate of approximately 50% after six cycles with an adequate response to treatment.

Authors

Institutions

Publication Details

Journal
International Journal of Research in Medical Sciences
Published
2025-01-10
DOI
https://doi.org/10.18203/2320-6012.ijrms20250017
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diffuse large B-cell lymphoma, multilocalized and extranodal in adult with complete remission: a case report

J.J. González, Aleyda Téllez, Antonio José Calderón, Ana Rodríguez et al.
1 links
International Journal of Research in Medical Sciences
Lymphoma Diagnosis and Treatment
article

Diffuse large B-cell lymphoma, multilocalized and extranodal in adult with complete remission: a case report

J.J. González, Aleyda Téllez, Antonio José Calderón, Ana Rodríguez, Lina Marcela Valencia Cárdenas
article en

Abstract

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphomas. The current classification recognizes an expanding group of distinct entities, with this being the most common. Up to one-third of DLBCL cases may originate in nearly any organ, most commonly in the gastrointestinal tract, skin and soft tissues, bones, or genitourinary tract. A 52-year-old woman with no history of chronic degenerative diseases presented with severe abdominal pain, weight loss, and night sweats. As part of her evaluation, an abdominopelvic CT scan was performed, revealing splenomegaly with internal nodular lesions of undetermined origin, inguinal lymphadenopathy, and cutaneous involvement. A lymphoproliferative process was suggested among the differential diagnoses. Immunohistochemical studies confirmed DLBCL. The patient subsequently received treatment with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), achieving a cure rate of approximately 50% after six cycles with an adequate response to treatment.

International Journal of Research in Medical Sciences
Autonomous University of Yucatán (MX), Institute for Social Security and Services for State Workers (MX), Universidad Nacional Autónoma de México (MX)
Good health and well-being
Openalex Percentile: Top 99%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.